About Refex Life Sciences Private Limited
Data last updated:
Refex Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Sherisha Technologies Private Limited. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 03 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33112TN2021PTC141761. Its GSTIN is 33AAUCA8721D1ZN (Tamil Nadu).
The company has an authorised share capital of ₹500 Cr and a paid-up capital of ₹162.13 Cr. It is led by directors Dinesh Kumar Agarwal and Anil Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, a growth of 146% compared to the previous year. For the same year it recorded a net loss of ₹8.14 Cr (net margin -167.3%) and EBITDA of -₹4.95 Cr (EBITDA margin -101.7%). Revenue has grown at a compounded annual rate (CAGR) of 559% over three years.
As per MCA filings, the company has open charges of ₹460 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website refex.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSecond Floor Refex Towers Sterling Road Signal, 313 Valluvar Kottam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Auditor Details of Refex Life Sciences Private Limited
Refex Life Sciences Private Limited is audited by ABCD & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABCD & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Refex Life Sciences Private Limited
Refex Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar Agarwal | Director | 03 Mar 2021 | 5 Years 7 Months | Current |
| Anil Jain | Additional Director | 11 Nov 2025 | 0 Years 10 Months | Current |
Financials of Refex Life Sciences Private Limited FY 2025 filings available
Refex Life Sciences Private Limited reported revenue of ₹4.86 Cr (up 146% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Refex Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 559% over three years, including 146% growth in the latest year. EBITDA fell 390% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Refex Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹4.95 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Refex Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -101.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -167.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Refex Life Sciences are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Refex Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Refex Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹335 Cr | Open |
| 17 May 2023 | Others | ₹125 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Refex Life Sciences Private Limited
Refex Life Sciences Private Limited has a workforce of 0 employees as of Mar 22, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Refex Life Sciences Private Limited
Refex Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAUCA8721D1ZN | Tamil Nadu | Active | 15 Mar 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Refex Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Refex Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Refex Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Refex Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Refex Life Sciences Private Limited
Frequently Asked Questions about Refex Life Sciences Private Limited
Refex Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 03 March 2021 (5+ years old) and is registered under CIN U33112TN2021PTC141761.
Refex Life Sciences reported revenue of ₹4.86 Cr for FY 2025 (up 146% YoY).
Refex Life Sciences has 2 current directors:
- Dinesh Kumar Agarwal - Director
- Anil Jain - Additional Director
Refex Life Sciences reported a net loss of ₹8.14 Cr (net margin -167.3%) and EBITDA of -₹4.95 Cr (EBITDA margin -101.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Refex Life Sciences is 559% over three years. In the latest year (FY 2025) revenue rose 146%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Refex Life Sciences is 33AAUCA8721D1ZN, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Refex Life Sciences is U33112TN2021PTC141761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Refex Life Sciences was incorporated on 03 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Refex Life Sciences can be reached through the website refex.co.in. Its registered office is in Chennai, Tamil Nadu, India.